The Food and Drug Administration in the United States has just approved the Olumiant (baricitinib) to treat adults with severe alopecia. This disorder often appears as patchy baldness and affects more than 300,000 people in this country yearly.
I will give you just the right amount of love!
Every week I send out new art, writing, and interesting links. It's free, no spam, and unsubscribe whenever you want.